Have a Question?
You can pose a question to the speaker by clicking on the "
" icon at the end of the session title. Appropriate questions will be answered during the session as time permits (not all questions will be answered).
Market Globally, Manufacture Locally. Geo Trends and Strategies in Biomanufacturing
Room: 1E18, 1E19, 1E20 ~ 12:30PM - 2:00PM (Wednesday, April 21, 2010)
| As of 2008, the 10 largest multinational biomanufacturers controlled ~80% of world capacity, concentrated in North America and Europe. With the global recession, mergers, technological advances, and the entry of China and India, there may even be excess global capacity.
However, factors such as emerging countries’ growing demand; new technologies (e.g., single-use, automation); supply chain and biosecurity concerns, are driving interest in smaller, more geographically distributed production. A panel of global experts will forecast geographic trends and discuss strategies to turn geographic constraints into opportunities for safer, cheaper, faster and better biological products.
Topics covered include:
• A global bioeconomy: globalization vs. national interest, protectionism vs. free trade, the growth of outsourcing vs. current capacity concentrations, cost vs. control
• Legal and regulatory: IP and patents, the global regulatory framework, GMP and market approval, supply-chain risk, the threat/opportunity of biogenerics/biosimilars
• Technological change and comparative advantage: automation, disposables, infrastructure, disruptive technologies, labor supply, IP
• Biosecurity and safety: cost vs. safety, pandemic preparation, vaccines demand, supply-chain contamination risks bioterrorism, biodefense R&D funding opportunities Moderator:Speaker:Mani Krishnan - Director Mobius Single-Use Processing Systems, Millipore Corporation Tom Ransohoff - BioProcess Technology Consultants, VP & Senior Consultant Mike Ultee - Vice President of Process Sciences, Laureate Pharma |